Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

Clinical trial NCT02742532 · COMPLETED

Trial details

NCT number: NCT02742532
Sponsor: Jennifer Mitchell
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder Stress Disorders, Post-Traumatic Anxiety Disorders Substance Use Disorders

Start date: 2017-04-20
Primary completion: 2019-07-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.